Fundraising FoxShoreline Biosciences
La Jolla, US · Founded 2020 · Delaware corporation · 17 known investors
Find your way into Shoreline Biosciences
Founders & leadership
Shoreline Biosciences was founded in 2020 by Dan S. Kaufman and Kleanthis G. Xanthopoulos, Ph.D..
DS
Dan S. KaufmanCo-founder
KG
Kleanthis G. Xanthopoulos, Ph.D.Co-founder
MF
Marios FotiadisNamed on SEC filing
SH
Steven HoltzmanNamed on SEC filing
Investors · 17
BeiGenereportedChangping
How we know: funding news · biospace.com · Not right? Tell us
Commodore CapitalreportedNew York
How we know: biospace.com · Not right? Tell us
Gilead SciencesreportedFoster City
How we know: funding news · Not right? Tell us
Irving InvestorsreportedNew York
How we know: biospace.com · Not right? Tell us
Also in the syndicate · 10
Boxer CapitalCormorant Asset ManagementEventide Asset ManagementKingdonKite PharmaNS InvestmentPiper Heartland Healthcare CapitalStork CapitalSuperstringWedbush Healthcare Partners
Reported raises · per SEC filings
Form D private placements$186M disclosed across 3 rounds · 2020–2021
▶$140MraisedNov 2021 · 25 investors · BiotechnologyRule 506(b)
▶$140MraisedNov 2021 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vanessa JacobyExecutive Officer
- William SandbornExecutive Officer
- Kimberly ManhardDirector
- Scott ForrestExecutive Officer
- Fan YuDirector
- Marios FotiadisDirector
- Steven HoltzmanDirector
- Christopher FuglesangDirector
- Kleanthis G. XanthopoulosExecutive Officer, Director
- Dan S. KaufmanDirector
- Offering amount
- $140M
- Amount sold
- $140M
- Sales commissions
- $2.8M
- Placement agents
- Wedbush Securities Inc.
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$43MraisedFeb 2021 · 20 investors · BiotechnologyRule 506(b)
▶$43MraisedFeb 2021 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dan S. KaufmanDirector
- Marios FotiadisDirector
- Steven HoltzmanDirector
- Kleanthis G. Xanthopoulos, Ph.D.Executive Officer, Director
- Christopher FuglesangDirector
- Offering amount
- $43M
- Amount sold
- $43M
- Sales commissions
- $1.4M
- Placement agents
- Wedbush Securities Inc.
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3MraisedJul 2020 · 6 investors · BiotechnologyRule 506(b)
▶$3MraisedJul 2020 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marios FotiadisDirector
- Steven HoltzmanDirector
- Dan S. KaufmanDirector
- Kleanthis G. Xanthopoulos, Ph.D.Executive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Shoreline Biosciences?
- Shoreline Biosciences was founded by Dan S. Kaufman, Kleanthis G. Xanthopoulos, Ph.D. in 2020.
- Who are Shoreline Biosciences's investors?
- Shoreline Biosciences's investors include Ally Bridge Group, BeiGene, Biotechnology Value Fund, Commodore Capital, Gilead Sciences, Irving Investors, Janus Henderson Investors.
- How much funding has Shoreline Biosciences raised?
- Shoreline Biosciences has disclosed $186M raised across 3 rounds.
- Where is Shoreline Biosciences headquartered?
- Shoreline Biosciences is headquartered in La Jolla, US.